Main Menu

Professor Nick Turner

Group Leader

The alt text
Professor Nicholas Turner is an Academic Consultant Medical Oncologist who specialises in breast cancer treatment. He is a Group Leader in the Breast Cancer Now Toby Robins Research Centre and Chief Investigator of many national and international trials of personalised breast cancer therapy. Group: Molecular Oncology
+44 20 7153 5574 ORCID 0000-0001-8937-0873


Professor Nicholas Turner is a Consultant Medical Oncologist who specialises in the treatment of breast cancer. He read Natural Sciences at Cambridge University before qualifying in 1997 from the University of Oxford Medical School.

After completing general medical training in London, he trained in medical oncology at The Royal Free and University College Hospitals and completed a PhD at The Institute of Cancer Research in 2006. He joined the Breast Unit of The Royal Marsden as a Consultant in Medical Oncology in 2008. He was elected a fellow of the Academy of Medical Sciences in 2021.

See all news stories on our website that feature the work of Professor Turner and colleagues.

Read news

He is the Director of The Royal Marsden and ICR NIHR Biomedical Research Centre, and Director of Clinical Research at The Royal Marsden and ICR. He is Head of the Ralph Lauren Centre for Breast Cancer Research and Group Leader in Molecular Oncology at the Breast Cancer Now Research Centre at the Institute of Cancer Research (ICR).

He has been awarded multiple prizes for his research including the AACR Outstanding Investigator Award for Breast Cancer Research in 2017, the AACR Team Science Award in 2022, the Pezcoller Foundation – EACR Translational Cancer Researcher Award in 2022, the ESMO award for Translational Research in 2023, and the Queen’s Anniversary Prize 2024.  

Professor Turner has co-chaired the ASCO/CAP and chaired the ESMO review committees on circulating tumour DNA analysis in patients with cancer. He sits on the organising committees of many international conferences on breast cancer, was the executive chair of the IMPAKT 2015 breast cancer conference, chair of the ESMO Breast Cancer 2025 conference, and is a scientific editor of the journal Cancer Discovery.

He is Chief Investigator of a number of national and international trials of precision therapy in breast cancer. His research interests include the development of new therapies for breast cancer and using liquid biopsies to deliver more precise treatment for breast cancer.

Professor Turner is a member of the Cancer Research UK Convergence Science Centre, which brings together leading researchers in engineering, physical sciences, life sciences and medicine to develop innovative ways to address challenges in cancer.

Convergence Science Centre